NanoGroup S.A. (WSE:NNG)

Poland flag Poland · Delayed Price · Currency is PLN
2.720
-0.050 (-1.81%)
At close: Dec 5, 2025
-2.16%
Market Cap 87.49M
Revenue (ttm) -6.90K
Net Income (ttm) -6.93M
Shares Out 32.16M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 75,005
Average Volume 79,676
Open 2.845
Previous Close 2.770
Day's Range 2.645 - 2.845
52-Week Range 2.200 - 3.830
Beta 0.70
RSI 48.63
Earnings Date Nov 28, 2025

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Country Poland
Stock Exchange Warsaw Stock Exchange
Ticker Symbol NNG
Full Company Profile

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.

Financial Statements

News

There is no news available yet.